MTIP

GROWTH CAPITAL DECISIONS – AN INTERVIEW WITH OUR CO-FOUNDER & MANAGING PARTNER DR
CHRISTOPH KAUSCH
RAHEL HAFNER RECEIVES CERTIFICATE IN ESG INVESTING BY CFA INSTITUTE
Rahel Hafner Receives Certificate in ESG Investing
WHAT MAKES A GREAT FOUNDER/INVESTOR RELATIONSHIP?
Interview with the CEO and Co-Founder Kai Eberhardt of our portfolio company Oviva
MTIP’S HEALTHCARE CLINIC 2022
This year's HealthCare Clinic was held under the motto: "Surfing the Healthtech Waves of Change"

CHRISTOPH KAUSCH SELECTED BY REAL DEALS AS MOST INFLUENTIAL FOR 2022
Christoph Kausch named by Real Deals most influential for 2022
MTIP LEADS €17 MILLION FINANCING ROUND IN VIRTUAL FERTILITY CLINIC APRICITY
MTIP LEADS THE €20 MILLION GROWTH FINANCING ROUND IN LYNXCARE
Largest capital round ever in digital health in Belgium
PIONEERING THE USE OF MACHINE LEARNING ALGORITHMS TO TURBO-CHARGE DRUG DEVELOPMENT
Intelligencia revolutionizes drug development
THE PSYCHOLOGY OF DECISION MAKING
What makes a good investor?
REVOLUTIONIZING MEDICAL TRIAGE WITH ARTIFICIAL INTELLIGENCE
Mediktor's solution for medical triage
MTIP CLOSES SECOND HEALTHTECH GROWTH FUND ABOVE TARGET WITH $250M OF COMMITMENTS
MTIP Fund II is closed!
CYNERIO NOW! – A NEW IOT CYBERSECURITY SOLUTION FOR SMALL HOSPITALS AND CLINICS
Cynerio's new product Cynerio Now!
MTIP INVESTS IN MEDIKTOR
New investment in Mediktor
SFDR ART
8 OR ART
9? WHAT’S THE DIFFERENCE?
SFDR: getting the terminology right
MTIP PARTICIPATES IN OVIVA’S NEW $80M SERIES C FUNDING
Oviva raises $80 million financing round
MTIP INVESTS IN INTELLIGENCIA TO REDUCE THE RISK OF CLINICAL RESEARCH THROUGH ARTIFICIAL INTELLIGENCE